Skip to main content
. 2021 Apr 26;101(4):799. doi: 10.2340/00015555-3805

Fig. 1.

Fig. 1

(a) Hyperkeratotic skin lesions on the soles in Case 3. (b) Apremilast resulted in a striking improvement of skin lesions within 3 months. (c) The yellowish hyperkeratosis and scaly erythema in Case 6. (d) Apremilast resulted in a striking improvement of palmoplantar keratoderma (PPK) within 2 months.